On May 6, 2021 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, reported the Company’s CEO Dr. Pnina Fishman will present at Benzinga’s Global SmallCap Conference on Thursday, May 13, 2021 at 11:10 a.m. ET on the Transformative Healthcare track (Press release, Can-Fite BioPharma, MAY 6, 2021, View Source [SID1234579404]). Investors interested in viewing Can-Fite’s presentation may register with free access for the two-day conference which takes place virtually on May 13 and 14, 2021 here: View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Fishman will give an overview of Can-Fite’s psoriasis, liver cancer and NASH study results which together demonstrate a clinical proof of concept for its platform technology with drug candidates in Phase II and Phase III. An update on the Company’s cannabis work will be presented as well.